
ASSOCIATION OF THE –308 (G->A) POLYMORPHISM OF TUMOR NECROSIS FACTOR α WITH MYOCARDIAL INFARCTION AND SUDDEN CARDIAC DEATH Tulyakova G1,*, Nasibullin T1, Salmanov A2, Avzaletdinova D1,
Khusnutdinova E1, Zakirova A3, Mustafina O1 *Corresponding Author: Dr. Gulnara Tulyakova, Institute of Biochemistry and Genetics, Ufa Research Center, Russian Academy of Sciences, October Avenue 69, 450054, Ufa, Bashkortostan, Russia; Tel.: +7-3472-361176; Fax: +7-3472-356100; E-mail: gulnarat@mail.ru page: 31
|
RESULTS
The genotype and allele frequencies in healthy controls and in groups A and B are presented in Table 1. The genotype distribution in the control group fitted the Hardy-Weinberg equilibrium (p = 1.0 c2 = 0.099).
There was a tendency for an increase in frequency of the TNFA1 allele and a decrease in frequency of the TNFA2 allele in Group A (p = 0.06) compared with the control group. The distribution of the genotypes and alleles between group B and the controls did not differ significantly. The comparison of two study groups showed that the TNFA1/2 genotype and TNFA2 allele frequencies in Group B were significantly higher than in Group A, whereas those of TNFA1/1 genotype and TNFA1 allele were lower. OR for the TNFA1/2 genotype and TNFA2 allele were 2.09 and 1.68, respectively.
Table 1. Genotype and allele frequencies of the –308 (G®A) polymorphism of the TNF-a gene in myocardial infarction patients (group A), sudden cardiac death individuals (group B) and healthy controls from Ufa, Bashkortostan, Russia.
Genotype or Allele |
Control (n = 246) |
Group A (n = 306) |
Group B (n = 149) |
|
n |
p% |
n |
p% |
n |
p% |
p |
TNFA1/1 |
177 |
71.95 |
242 |
79.08 |
98 |
65.77 |
0.003 |
TNFA1/2 |
64 |
26.02 |
61 |
19.93 |
51 |
34.23 |
0.001 |
TNFA2/2 |
5 |
2.03 |
3 |
0.98 |
0 |
0 |
0.554 |
TNFA1/2 + TNFA2/2 |
69 |
28.05 |
64 |
20.91 |
51 |
34.23 |
0.003 |
TNFA1 |
418 |
84.96 |
545 |
89.05 |
247 |
82.89 |
0.007 |
TNFA2 |
74 |
15.04 |
67 |
10.95 |
51 |
17.11 |
0.007 |
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|